Lorazepam
Product Images NDC 64725-6044

2 FDA label images from Tya Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 64725-6044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 6044)

Label Image (64725 6044)
Lorazepam injectable solution label showing 2 mg/mL strength in 25 x 1 mL units. The label includes prescription-only status, lot number, expiration date, manufacturer West-Ward, and repackager T.Y.A Pharmaceuticals located in Tallahassee, FL. A barcode and a note to see package insert for dosing are also present.*
FDA Label Image

Lorazepam Injection Structural Formula (Lorazepam Injection Usp Ww 1)

Lorazepam Injection Structural Formula (Lorazepam Injection Usp   Ww 1)
Chemical structure of Lorazepam, showing the characteristic benzodiazepine ring with chloro substituents and hydroxyl group as part of its molecular framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.